Guggenheim Capital LLC Bio N Tech Se Transaction History

Guggenheim Capital LLC

$13.9 Billion
Q2 2024

A detailed history of Guggenheim Capital LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Guggenheim Capital LLC holds 13,199 shares of BNTX stock, worth $1.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,199

Previous 21,170 37.65%

Holding current value

$1.56 Million

Previous $1.95 Million 45.7%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $640,549 - $819,976	-7,971 Reduced 37.65%	13,199 $1.06 Million
Q1 2024 May 14, 2024	BUY	$88.96 - $112.35 $264,300 - $333,791	2,971 Added 16.33%	21,170 $1.95 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $77,546 - $96,175	-853 Reduced 4.48%	18,199 $1.92 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $390,552 - $495,942	-3,965 Reduced 17.23%	19,052 $2.07 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $665,641 - $841,363	6,489 Added 39.26%	23,017 $2.48 Million
Q1 2023 May 10, 2023	BUY	$122.57 - $153.67 $152,844 - $191,626	1,247 Added 8.16%	16,528 $2.06 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $275,705 - $433,124	-2,328 Reduced 13.22%	15,281 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $407,075 - $583,937	-3,189 Reduced 15.33%	17,609 $2.38 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $428,047 - $646,811	-3,473 Reduced 14.31%	20,798 $3.1 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $411,070 - $754,903	3,256 Added 15.49%	24,271 $4.14 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $1.36 Million - $2.28 Million	6,294 Added 42.76%	21,015 $5.42 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $400,327 - $869,415	-1,944 Reduced 11.67%	14,721 $4.02 Million
Q2 2021 Aug 13, 2021	SELL	$113.32 - $241.49 $1.77 Million - $3.77 Million	-15,628 Reduced 48.39%	16,665 $3.73 Million
Q1 2021 May 13, 2021	SELL	$85.73 - $119.5 $214,496 - $298,989	-2,502 Reduced 7.19%	32,293 $3.53 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $2.53 Million - $4.51 Million	34,795 New	34,795 $2.84 Million

Others Institutions Holding BNTX

# of Institutions

328

Shares Held

40.6M

Call Options Held

845K

Put Options Held

1.23M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Bio N Tech Se Transaction History